Status:
COMPLETED
Multisystemic Therapy to Reduce Health Disparities in Adolescents With Asthma
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Asthma
Eligibility:
All Genders
12-16 years
Phase:
NA
Brief Summary
Asthma is a chronic lung disease that inflames and narrows the airways. Symptoms can include recurring periods of wheezing, chest tightness, shortness of breath, and coughing. Minority, inner city tee...
Detailed Description
Although rates of childhood asthma are increasing worldwide, more alarming is the disproportionate rise in rates of asthma among urban, disadvantaged, minority children. Inner city children, particula...
Eligibility Criteria
Inclusion
- Moderate to severe persistent asthma
- African American
- One or more hospitalizations for asthma in the last 12 months
Exclusion
- No exclusions will be made due to co-morbid mental health problems (i.e., attention deficit hyperactivity disorder \[ADHD\], conduct disorder, depression, anxiety disorder), with the exception of thought disorder (i.e. schizophrenia, autism), suicidality, or mental retardation
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2013
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT00916240
Start Date
September 1 2008
End Date
June 1 2013
Last Update
August 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wayne State University School of Medicine
Detroit, Michigan, United States, 48201